Despite these positive signs, Incyte's shares have been slammed by the negative results of phase three trials in recent years, creating a sort of stigma around its one-drug label.Based in Santa Clara, California, Palo Alto Networks is a cybersecurity company with core products that include advanced and cloud-based firewalls.